vs
Side-by-side financial comparison of POWER SOLUTIONS INTERNATIONAL, INC. (PSIX) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $191.2M, roughly 1.5× POWER SOLUTIONS INTERNATIONAL, INC.). Bio-Techne runs the higher net margin — 12.8% vs 8.4%, a 4.4% gap on every dollar of revenue. On growth, POWER SOLUTIONS INTERNATIONAL, INC. posted the faster year-over-year revenue change (32.5% vs -6.4%). Over the past eight quarters, POWER SOLUTIONS INTERNATIONAL, INC.'s revenue compounded faster (41.7% CAGR vs 4.2%).
Adani Energy Solutions Ltd, formerly known as Adani Transmission Ltd, is an electric power transmission and distribution company headquartered in Ahmedabad. As of April 2025, the company operates a cumulative transmission network of 26,696 circuit kilometers and is one of the largest private sector power transmission companies operating in India.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
PSIX vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $191.2M | $295.9M |
| Net Profit | $16.1M | $38.0M |
| Gross Margin | 21.9% | 64.6% |
| Operating Margin | 12.7% | 18.4% |
| Net Margin | 8.4% | 12.8% |
| Revenue YoY | 32.5% | -6.4% |
| Net Profit YoY | -31.0% | 68.3% |
| EPS (diluted) | $0.69 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $191.2M | $295.9M | ||
| Q3 25 | $203.8M | — | ||
| Q2 25 | $191.9M | $317.0M | ||
| Q1 25 | $135.4M | $316.2M | ||
| Q4 24 | $144.3M | $297.0M | ||
| Q3 24 | $125.8M | $289.5M | ||
| Q2 24 | $110.6M | $306.1M | ||
| Q1 24 | $95.2M | $303.4M |
| Q4 25 | $16.1M | $38.0M | ||
| Q3 25 | $27.6M | — | ||
| Q2 25 | $51.2M | $-17.7M | ||
| Q1 25 | $19.1M | $22.6M | ||
| Q4 24 | $23.3M | $34.9M | ||
| Q3 24 | $17.3M | $33.6M | ||
| Q2 24 | $21.5M | $40.6M | ||
| Q1 24 | $7.1M | $49.1M |
| Q4 25 | 21.9% | 64.6% | ||
| Q3 25 | 23.9% | — | ||
| Q2 25 | 28.2% | 62.7% | ||
| Q1 25 | 29.7% | 67.9% | ||
| Q4 24 | 29.9% | 65.3% | ||
| Q3 24 | 28.9% | 63.2% | ||
| Q2 24 | 31.8% | 66.4% | ||
| Q1 24 | 27.0% | 67.4% |
| Q4 25 | 12.7% | 18.4% | ||
| Q3 25 | 13.9% | — | ||
| Q2 25 | 16.9% | -7.5% | ||
| Q1 25 | 18.2% | 12.2% | ||
| Q4 24 | 17.5% | 16.0% | ||
| Q3 24 | 16.3% | 13.8% | ||
| Q2 24 | 22.9% | 15.0% | ||
| Q1 24 | 11.2% | 22.1% |
| Q4 25 | 8.4% | 12.8% | ||
| Q3 25 | 13.5% | — | ||
| Q2 25 | 26.7% | -5.6% | ||
| Q1 25 | 14.1% | 7.1% | ||
| Q4 24 | 16.1% | 11.7% | ||
| Q3 24 | 13.8% | 11.6% | ||
| Q2 24 | 19.5% | 13.3% | ||
| Q1 24 | 7.5% | 16.2% |
| Q4 25 | $0.69 | $0.24 | ||
| Q3 25 | $1.20 | — | ||
| Q2 25 | $2.22 | $-0.11 | ||
| Q1 25 | $0.83 | $0.14 | ||
| Q4 24 | $1.01 | $0.22 | ||
| Q3 24 | $0.75 | $0.21 | ||
| Q2 24 | $0.94 | $0.26 | ||
| Q1 24 | $0.31 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.3M | $172.9M |
| Total DebtLower is stronger | $96.6M | $260.0M |
| Stockholders' EquityBook value | $178.6M | $2.0B |
| Total Assets | $424.7M | $2.5B |
| Debt / EquityLower = less leverage | 0.54× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $41.3M | $172.9M | ||
| Q3 25 | $49.0M | — | ||
| Q2 25 | $49.5M | $162.2M | ||
| Q1 25 | $50.0M | $140.7M | ||
| Q4 24 | $55.3M | $177.5M | ||
| Q3 24 | $40.5M | $187.5M | ||
| Q2 24 | $28.8M | $152.9M | ||
| Q1 24 | $33.1M | $145.3M |
| Q4 25 | $96.6M | $260.0M | ||
| Q3 25 | $96.7M | — | ||
| Q2 25 | $1.8M | $346.0M | ||
| Q1 25 | $1.0M | $330.0M | ||
| Q4 24 | $184.0K | $300.0M | ||
| Q3 24 | $238.0K | $300.0M | ||
| Q2 24 | $292.0K | $319.0M | ||
| Q1 24 | $345.0K | $389.0M |
| Q4 25 | $178.6M | $2.0B | ||
| Q3 25 | $162.5M | — | ||
| Q2 25 | $135.7M | $1.9B | ||
| Q1 25 | $84.3M | $2.0B | ||
| Q4 24 | $65.3M | $2.1B | ||
| Q3 24 | $42.1M | $2.1B | ||
| Q2 24 | $24.8M | $2.1B | ||
| Q1 24 | $3.2M | $2.0B |
| Q4 25 | $424.7M | $2.5B | ||
| Q3 25 | $458.9M | — | ||
| Q2 25 | $437.7M | $2.6B | ||
| Q1 25 | $372.7M | $2.6B | ||
| Q4 24 | $328.2M | $2.7B | ||
| Q3 24 | $339.1M | $2.7B | ||
| Q2 24 | $307.6M | $2.7B | ||
| Q1 24 | $286.8M | $2.7B |
| Q4 25 | 0.54× | 0.13× | ||
| Q3 25 | 0.60× | — | ||
| Q2 25 | 0.01× | 0.18× | ||
| Q1 25 | 0.01× | 0.16× | ||
| Q4 24 | 0.00× | 0.14× | ||
| Q3 24 | 0.01× | 0.14× | ||
| Q2 24 | 0.01× | 0.15× | ||
| Q1 24 | 0.11× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.6M | — |
| Free Cash FlowOCF − Capex | $-7.6M | — |
| FCF MarginFCF / Revenue | -4.0% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | -0.29× | — |
| TTM Free Cash FlowTrailing 4 quarters | $14.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.6M | — | ||
| Q3 25 | $3.3M | — | ||
| Q2 25 | $16.7M | $98.2M | ||
| Q1 25 | $8.8M | $41.1M | ||
| Q4 24 | $32.7M | $84.3M | ||
| Q3 24 | $12.6M | $63.9M | ||
| Q2 24 | $1.5M | $75.5M | ||
| Q1 24 | $15.6M | $81.0M |
| Q4 25 | $-7.6M | — | ||
| Q3 25 | $1.7M | — | ||
| Q2 25 | $14.6M | $93.3M | ||
| Q1 25 | $5.4M | $31.0M | ||
| Q4 24 | $30.0M | $77.5M | ||
| Q3 24 | $12.1M | $54.7M | ||
| Q2 24 | $822.0K | $57.5M | ||
| Q1 24 | $14.8M | $64.5M |
| Q4 25 | -4.0% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 7.6% | 29.4% | ||
| Q1 25 | 4.0% | 9.8% | ||
| Q4 24 | 20.8% | 26.1% | ||
| Q3 24 | 9.7% | 18.9% | ||
| Q2 24 | 0.7% | 18.8% | ||
| Q1 24 | 15.6% | 21.3% |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 1.1% | 1.5% | ||
| Q1 25 | 2.5% | 3.2% | ||
| Q4 24 | 1.8% | 2.3% | ||
| Q3 24 | 0.3% | 3.2% | ||
| Q2 24 | 0.6% | 5.9% | ||
| Q1 24 | 0.9% | 5.4% |
| Q4 25 | -0.29× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 0.46× | 1.82× | ||
| Q4 24 | 1.40× | 2.42× | ||
| Q3 24 | 0.73× | 1.90× | ||
| Q2 24 | 0.07× | 1.86× | ||
| Q1 24 | 2.20× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PSIX
| Energy End Market | $153.4M | 80% |
| Industrial End Market | $33.3M | 17% |
| Transportation End Market | $4.6M | 2% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
